Tag: Depression
FDA Clears Deep TMS™ for Adolescents With Major Depressive Disorder
The FDA has cleared BrainsWay’s Deep TMS™ system as an adjunct treatment for adolescents aged 15–21 with major depressive disorder, expanding access to a noninvasive, evidence-based therapy previously available only to adults.
Health Technology Assessment: Virtual Solutions for Depression and Anxiety
Depression and anxiety affect over 1 in 5 U.S. adults. Despite increased screening, access to effective treatment remains limited. In response, virtual mental health solutions are emerging to close this gap by offering accessible, scalable care options. PHTI conducted an
Transforming Mental Health Care With Prescription Digital Therapeutics
Even as technological changes transform many aspects of daily life, the treatment of mental health disorders, which affect approximately 97 million people worldwide1, has remained largely unchanged for decades.
Upcoming Events
Webinar Replays
Member Login
Our Audience
eMHIC has and audience of 12 member countries (and growing) with thousands of subscribers around the world.
Share your thoughts
Have quality news or resources to share on the eMHIC Knowledge Bank? We’d love to consider publishing them for our global community.
